 |
electrokinetically altered saline solution with an elevated dissolved oxygen concentration |
|---|---|
| Trade Name | |
| Orphan Indication | Amyotrophic lateral sclerosis |
| USA Market Approval | USA |
| USA Designation Date | 2017-07-10 00:00:00 |
| Sponsor | Revalesio Corporation;1202 East D Street;Tacoma, Washington, 98421 |
